Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(37.5%)

Phase 2

3(37.5%)

Phase 1

2(25.0%)

8Total

N/A(3)

Phase 2(3)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07549646Phase 2Active Not Recruiting

24VA021; VATCH Trametinib for Ras/MAPK Pathway VAs

Role: collaborator

NCT07543822Phase 2Active Not Recruiting

24VA022; VATCH Alpelisib for TIE2/PIK3CA Pathway VAs

Role: collaborator

NCT05071144Recruiting

Advanced SPinal Innovations With Robotics and Enabling Technology Registry

Role: collaborator

NCT05681624Not ApplicableRecruiting

Maternal Oxygen Supplementation for Intrauterine Resuscitation

Role: collaborator

NCT07221760Phase 1Not Yet Recruiting

Personalized Antisense Oligonucleotide for A Single Participant (nL62541) With ATN1 Gene Mutation

Role: collaborator

NCT00674388Recruiting

The Pediatric Anesthesia Quality Improvement Project

Role: collaborator

NCT05433155Not ApplicableCompleted

Nasotracheal Intubation With VL vs DL in Infants Trial

Role: collaborator

NCT04997291Phase 1Unknown

Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery

Role: collaborator

NCT03003390Phase 2Terminated

Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial

Role: collaborator

NCT03288857Not ApplicableCompleted

Comparison of the Bulb Aspirator to a Nasal Oral Aspirator in the Treatment of Bronchiolitis

Role: collaborator

All 10 trials loaded